2016
DOI: 10.1016/j.chest.2015.09.026
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Atrial Fibrillation in Patients With Chronic Kidney Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…Of note, both stroke and bleeding risk increase at lower GFRs, [3][4][5][6] such that there is less certainty regarding the benefits and risks associated with anticoagulation treatment in individuals with advanced CKD and AF. 7 In this issue of AJKD, Jun et al 8 present results of an observational investigation evaluating the overall safety and effectiveness of warfarin for thromboembolism prophylaxis in patients with AF according to level of estimated GFR. This study included data from patients 66 years and older (mean, 78 years) with and without reduced GFR from Alberta, Canada, who had coexisting nonvalvular AF.…”
mentioning
confidence: 99%
“…Of note, both stroke and bleeding risk increase at lower GFRs, [3][4][5][6] such that there is less certainty regarding the benefits and risks associated with anticoagulation treatment in individuals with advanced CKD and AF. 7 In this issue of AJKD, Jun et al 8 present results of an observational investigation evaluating the overall safety and effectiveness of warfarin for thromboembolism prophylaxis in patients with AF according to level of estimated GFR. This study included data from patients 66 years and older (mean, 78 years) with and without reduced GFR from Alberta, Canada, who had coexisting nonvalvular AF.…”
mentioning
confidence: 99%